AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05573009 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cognitive behavioral approach-based stress reduction program
Description: Five days lasting stress reduction program based on cognitive behavioral approach(each session will be an average of 60 minutes) will be initiated in the third day of hospitalisation to the intervention group.~Session main topics are:~Session 1 - Introducing the purpose and content of the program - Stress Psychoeducation Session 2 - Cognitive restructuring Session 3 -Behavioral coping Session 4 - Problem solving training Session 5-Upcoming parenthood
Study NCT05449353 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Trauma-informed Cognitive Behaviour Therapy (TiCBT)
Description: Group: Experimental (n=24 participants) will receive the TiCBT which consists of a total of 8-group integrated sessions lasting approximately 60 minutes per session every 3 days interval with 24 persons in the single group.
Study NCT06511414 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: duramesh
Description: Duramesh™ non-absorbable polypropylene suture is a hollow core, microporous, cylindrical suture made off in polypropylene filaments that are loosely braided and bonded to each other with heat and pressure
Study NCT06511414 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: standard closure of fascia
Study NCT06251180 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: 100 mg orally once on Day 1 to Day 5 in a 21-day cycle for six cycles.
Study NCT05458622 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Saliva sample
Description: - Saliva: will be collect in special container for saliva microbiome and methylation;
Study NCT05458622 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Stood sample
Description: - Stool: One sample for microbiome to be sent to the biobank, frozen at -80 °C
Study NCT05458622 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Tissue sample
Description: - Tissue samples for organ-specific manifestations:~* Kidney tissue in lupus nephritis: one small fragment of the fresh kidney biopsy will be stored in a 10% dimethyl sulfoxide (DMSO) solution (slow freezing to -80 °C) until shipment.~* Skin tissue (at selected centers) from inflamed lesion and non-inflamed skin from the gluteal region will be obtained through punch biopsy and stored in a 10% dimethyl sulfoxide (DMSO) solution (slow freezing to -80 °C) until shipment.~* Synovial tissue (at selected centers) will be obtained through ultrasound-directed arthroscopy and stored in a 10% dimethyl sulfoxide (DMSO) solution (slow freezing to -80 °C) until shipment.~* Aspirate from swollen lymph nodes (at selected centers) will be obtained and stored in a 10% dimethyl sulfoxide (DMSO) solution (slow freezing to -80 °C) until shipment.
Study NCT05660135 — intervention group
Intervention type: DRUG
Intervention: Olmesartan Medoxomil/ Amlodipine Besylate/ Rosuvastatin Ca
Description: Olomax Tab 20/5/5mg Olomax Tab 20/5/10mg Olomax Tab 40/5/5mg Olomax Tab 40/5/10mg
Study NCT04983498 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ondansetron 4 MG
Description: PONV prophylaxis for participants with an apfel score of 2 or greater (ondansetron 4 mg IV), an additional dose of ondansetron 4mg IV will be available in recovery if the patient has nausea/vomiting despite prophylaxis.
Study NCT04983498 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lactated Ringers, Intravenous
Description: Goal directed IV fluids to be administered starting preop per the NMH Colorectal ERAS protocol (LR @ 5mL/kg/hr).
Study NCT04983498 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Early Mobilization
Description: Patient transferred up to the chair (within 5-30 minutes of admission to the recovery room) based on nursing parameters and patient safety.
Study NCT04983498 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Early PO Intake
Description: Patient will be offered PO intake within 15-30 minutes of admission to the recovery room post-procedure based on nursing parameters and patient safety.
Study NCT04874441 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Diagnosis strategy based on C. glabrata / krusei PCR
Description: For diagnosis, a blood cultures and blood tubes for PCR will be collected and patients will be treated with echinocandins in the first instance with an early switch to fluconazole if the C. glabrata / krusei PCR is negative
Study NCT05161156 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Test Product (tiotropium bromide inhalation powder)
Description: A single dose of test product
Study NCT05161156 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: 18 mcg of Spiriva (Reference Product)
Description: A single dose of reference product (Spiriva)
Study NCT05161156 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Placebo
Description: A single dose of placebo
Study NCT05161156 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: A single dose of placebo
Study NCT05161156 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: A single dose of placebo
Study NCT05105607 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D-4517.2
Description: Subcutaneous (SC) injection
Study NCT04942496 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chlorhexidine Gluconate
Description: Antimicrobial Skin Wash
Study NCT04942496 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Hibi Universal Bathing System
Description: Cloths used for patient bathing
Study NCT04942496 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: 0.1% SLS
Description: Positive control
Study NCT04942496 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Distilled Water
Description: Negative Control
Study NCT04599335 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 2% HA
Description: 2% HA
Study NCT04885010 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: probiotics
Description: participants will be given probiotics twice a day for 15 days
Study NCT04885010 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: participants will be given a placebo twice a day for 15 days
Study NCT06213805 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Minimally invasive microsclerostomy
Description: MIMS is a filtering glaucoma surgery, which consists of creating a sclero-corneal drainage channel, to allow the flow of aqueous humor and therefore the reduction of intraocular pressure.~This surgery is extremely quick, lasting 3 to 5 minutes, according to recent MIMS studies, in contrast to the duration of a trabeculectomy, the classic glaucoma surgery, which varies between 20 and 60 minutes.
Study NCT06673212 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Wheat Bread
Description: Ingredients: Wheat Flour, Salt, Water, Allinson's Dried Active Yeast, Sugar
Study NCT06673212 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Berneray Bere barley bread
Description: Ingredients: Berneray Bere Barley Flour, Salt, Water, Allinson's Dried Active Yeast, Sugar
Study NCT06673212 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Black Barley bread
Description: Ingredients: Black Barley Flour, Salt, Water, Allinson's Dried Active Yeast, Sugar
Study NCT03999216 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Loop Diuretics vs. loop + thiazide diuretics
Description: Participants will receive the diuretic type as determined by the randomized group assignment starting within the first 24 hours of hospital admission and continuing for up to 72 hours. All other treatments are left to the discretion of the treatment team, as this is a pragmatic randomized trial.
Study NCT05454683 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: melatonin plus zinc
Description: One capsule with melatonin 1mg plus zinc 10 mg o.d. 30 minutes before bedtime, at least 1 hour after dinner during 4 months
Study NCT05454683 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: isomaltose and magnesium stearate
Description: One capsule with excipients o.d. 30 minutes before bedtime, at least 1 hour after dinner during 4 months
Study NCT04972760 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Baricitinib
Description: Baricitinib, 4 mg/d, oral route for 24 weeks
Study NCT04972760 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo, 4 mg/d, oral route for 24 weeks
Study NCT05475678 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: （Carrelizumab + TCb） regimen
Description: Carrelizumab +docetaxel + carboplatin regimen
Study NCT05475678 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: TCb regimen
Description: docetaxel + carboplatin regimen
Study NCT06665802 — intervention group
Intervention type: BEHAVIORAL
Intervention: Questionnaire
Description: Questionnaire completion
Study NCT06667622 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sodium glycididazole
Description: Sodium glycididazole is intravenously infused at a dose of 800mg at 60 min before radiotherapy and used on Mondays, Wednesdays and Fridays during radiotherapy.
Study NCT06232031 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Active Breathing Exercises
Description: Active breathing exercises aim to enhance the strength and flexibility of respiratory muscles through a series of exercises, improving breathing patterns and increasing respiratory efficiency. The following are common components of active breathing exercises: 1) Deep Breathing. 2) Chest Expansion. 3) Diaphragmatic Breathing. 4) Coughing Techniques. 5) Expiratory Resistance Training. 6) Gradual Increase in Activity.
Study NCT06057428 — intervention group
Intervention type: PROCEDURE
Intervention: Decompressive surgery
Description: Decompressive surgery for lumbar spinal stenosis
Study NCT05756309 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electrocardiogram measurements by holter device and patch-type electrocardiographic at the same time
Description: The patient is measured electrocardiogram simultaneously through a holter device and patch-type electrocardiograph
Study NCT06544395 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Non invasive neuromodulation therapy
Description: In the 4 studies, the intervention consisted of 15 sessions spread over 5 weeks.~Each intervention lasted 60 minutes. The intensity will be programmed in all sessions at Low, following the Arndt-Schulz law. The treatment was distributed in 3 phases: phase 1 of preparation, phase 2 to reduce fatigue and phase 3 to enhance autonomic improvement.
Study NCT06544395 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Manual therapy
Description: Common manual therapy administered for said pathology by traditional physiotherapy and therapeutic exercise.
Study NCT06544395 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo with non invasive neuromodulation
Description: In the 4 studies, the intervention consisted of 15 sessions spread over 5 weeks.~Each intervention lasted 60 minutes. The treatment was carried out with the machine turned off.
Study NCT05697003 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 1000 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
Description: 2 inhalations in one study period
Study NCT05697003 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ADVAIR DISKUS 100/50
Description: 2 inhalations in one study period
Study NCT06386120 — intervention group
Intervention type: OTHER
Intervention: PEEP setting strategy
Description: The attending physician selects different PEEP setting strategies
Study NCT05648916 — intervention group
Intervention type: OTHER
Intervention: Celecoxib
Description: Retrospectively comparing patients with and without heterotopic ossification who have been exposed to celecoxib and underwent cementless total hip joint replacement surgery.
Study NCT06182722 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Mental assessments
Description: Patients will receive psychiatric rating scales evaluation every visit.
Study NCT05238428 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Trust boost
Description: The investigators adapt the wording of the vaccination invitation to foster trust and increase vaccination acceptance.
Study NCT05685771 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Phase-targeted auditory stimulation
Description: Bursts of pink noise (50 ms) played during deep non-REM sleep at specific phases of sleep slow waves.
Study NCT06258681 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Incentive spirometer
Description: The incentive spirometry group will continue training with Volumetric Triflo. It is asked to exhale at first and then hold their breath for at least 3 seconds after taking as deep a breath as possible.
Study NCT06258681 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Individualized respiratory training group
Description: Participants will be able to practice both inspiratory and expiratory respiratory muscle training in a single breathing cycle.
Study NCT06545474 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: bilateral theta burst stimulation
Description: Each stimulation session consists of 600 stimuli applied in bursts of 3 pulses at 50 Hz, with an interstimulus interval of 200 ms. iTBS is administered 20 times for 2 seconds to the left dlPFC, with an intertrain interval of 8 seconds and cTBS continuously for 40 seconds to the right dlPFC in alternating order.
Study NCT06545474 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SSRI treatment
Description: Participants receive 4 weeks SSRI treatment with escitalopram (10mg/day) as standard drug.
Study NCT06563401 — intervention group
Intervention type: OTHER
Intervention: prognosis of adult-onset t1d
Description: We are comparing mortality and vascular outcomes in adult-onset T1D to T2D and diabetes-free people
Study NCT05275244 — intervention group
Intervention type: DEVICE
Intervention: KD Intra-Articular® gel
Description: Depending on the joint, 3 injections will be administrated to the patient: KD Intra-Articular® gel 2.2% - 44 mg in 2 ml - (Pronolis® HD one 2.2%) in the case of shoulder and hip, or KD Intra-Articular® gel 1.6% - 16 mg in 1 ml - (Pronolis® HD mini 1.6%) in the case of the ankle and base of the thumb. The administration of the infiltrations will be with an interval of one week.
Study NCT04648241 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: TBE vaccine 0.5 mL
Description: TBE vaccine 0.5 mL (intramuscular injection).
Study NCT04648241 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: TBE vaccine 0.25 mL
Description: TBE vaccine 0.25 mL (intramuscular injection).
Study NCT05151965 — intervention group
Intervention type: PROCEDURE
Intervention: Bankart Repair and Remplissage
Description: Arthroscopic Bankart repair with a minimum of 3 anchors~1 or 2 anchor Remplissage subsequently performed with percutaneous anchor insertion in the base of the Hill-Sachs defect, and sutures passed in a horizontal mattress configuration 1 cm apart, tied in the subacromial space.
Study NCT05151965 — intervention group
Intervention type: PROCEDURE
Intervention: Latarjet Coracoid Transfer
Description: Coracoid transfer performed via deltopectoral approach with horizontal subscapularis split. Graft placed in the conventional orientation, secured with 2 screws, ensuring the graft is not lateral to the glenoid rim.
Study NCT05865249 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Spirometry decision support software (ArtiQ.Spiro)
Description: ArtiQ.Spiro is a decision support software that combines two sub-components - one focussing on quality assessment (ArtiQ.QC), and one on spirometry interpretation (ArtiQ.PFT). It is intended to be used as an adjunct to spirometry to assist with the grading of spirometry quality and the interpretation of spirometry by providing the probability of six disease / or no disease categories.
Study NCT06237127 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Goji berry
Description: Participants will be instructed to consume 28 grams of goji berries 5 days a week for 6 months
Study NCT06237127 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Fiber
Description: Participants will be instructed to consume the fiber supplements 5 days a week for 6 months
Study NCT06178913 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Description: The exercise intervention method is a circuit training method that combines strength training and aerobic exercise forms and consists of a total of 12 movements. Performing movements 1 to 12 in order is 1 set. After completing the set, when the heart rate returns to the plateau (less than 59% of maximum heart rate), proceed to the next set, for a total of 3 sets.
Study NCT06455254 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Candonilimab (AK104)
Description: Cadonilimab (AK104): 6mg/kg, i.v. q2w.
Study NCT06455254 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Regorafenib
Description: Regorafenib: 80 mg p.o. qd for 3 weeks of every 4 week cycle (i.e. 3 weeks on, 1 week off).
Study NCT05357170 — intervention group
Intervention type: OTHER
Intervention: Human feces collection
Description: Human feces collection and blood sampling
Study NCT05664815 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Human Amniotic Membrane
Description: After conventional/standard treatment, hAM will be applied in a single layer against the bone defect with, if possible, a burial of a few millimeters under the mucous edges.~With the idea of apprehending a possible dose effect, the hAM will be adapted to the size of the bone/mucous defect, mesenchymal side against the bone.~For closure after hAM grafting : 2 options are possible:~Edge-to-edge closure if sufficient mucosal laxity, Edge rapprochement by cross points. If necessary: possible incision of the periosteum to give laxity to the mucosa.
Study NCT05664815 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional/Standard treatment
Description: Surgical procedure: Endo-oral approach:~* Trimming of the mucous edges if they are necrotic or inflamed (granulation tissue)~* For the bone: either simple sequestrectomy (the mobile sequestered bone is grabbed using forceps); either reaming until bleeding is obtained; either resection with the rongeur; either monobloc resection of the entire necrotic fragment with a saw or with a piezzotome (ultrasound); or a combination of different techniques. Rq: the resection of the necrotic bone (according to the practices of the center) will operate until the appearance of an apparently healthy bone (bone bleeding, clean appearance of the bone site)~* Closure of the mucosa with possible incision of the periosteum to provide laxity: Suture points by points separated in one plane with non-absorbable braided thread of the 3.0 silk thread type and round needle.
Study NCT04755478 — intervention group
Intervention type: PROCEDURE
Intervention: Thoracotomy
Description: Participants will undergo lobectomy via open thoracotomy at the discretion of the surgical team.
Study NCT04755478 — intervention group
Intervention type: PROCEDURE
Intervention: VATS
Description: Participants will undergo lobectomy via VATS at the discretion of the surgical team.
Study NCT04983511 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Electrical Epidural Stimulation Test (EST)
Description: EST measures sensory/motor responses
Study NCT05769595 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MK-2060
Description: Lyophilized powder diluted in normal saline for IV infusion
Study NCT05769595 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: IV infusion
Study NCT05071066 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ADHD+
Description: The group-based intervention is designed to reduce participants' ADHD and related symptoms. The content of the treatment will follow an established manual which is developed by an expert group comprised of psychiatrists and clinical psychologists. Core treatment components include internet use/addiction intervention, cognitive training, emotion management, social skills training, occupational training, emotion support/befriending, parenting training, and career guidance.~The main intervention lasts for 3 months, and the booster intervention lasts for another 3 months. The post- intervention assessments (3-month \[T1\], and 6-month \[T2\]) will be administered to all participants. During the period of intervention, all participants shall be clean from other forms of interventions to reduce any other possible confounders.
Study NCT05071066 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: ADHD+
Description: The group-based intervention is designed to reduce participants' ADHD and related symptoms. The content of the treatment will follow an established manual which is developed by an expert group comprised of psychiatrists and clinical psychologists. Core treatment components include internet use/addiction intervention, cognitive training, emotion management, social skills training, occupational training, emotion support/befriending, parenting training, and career guidance.~The main intervention lasts for 3 months, and the booster intervention lasts for another 3 months. The post- intervention assessments (3-month \[T1\], and 6-month \[T2\]) will be administered to all participants. During the period of intervention, all participants shall be clean from other forms of interventions to reduce any other possible confounders.
Study NCT05486208 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3844583
Description: Administered SC and/or IV.
Study NCT05486208 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered SC and/or IV.